within Pharmacolibrary.Drugs.ATC.M;

model M01AG01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.00028333333333333335,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00106,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.01,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M01AG01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mefenamic acid is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for the treatment of mild to moderate pain, including menstrual pain (dysmenorrhea) and arthritis. It is still approved and used in clinical practice in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported from a study in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Yang, D, et al., &amp; Lou, H (2023). Drug-drug interaction of ciprofol injectable emulsion with mefenamic acid capsules in healthy subjects. <i>British journal of clinical pharmacology</i> 89(10) 3165–3174. DOI:<a href=&quot;https://doi.org/10.1111/bcp.15822&quot;>10.1111/bcp.15822</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37309663/&quot;>https://pubmed.ncbi.nlm.nih.gov/37309663</a></p></li><li><p>Prasad, E, et al., &amp; Halbert, GW (2022). Mefenamic acid solid dispersions: Impact of formulation composition on processing parameters, product properties and performance. <i>International journal of pharmaceutics</i> 616 121505–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ijpharm.2022.121505&quot;>10.1016/j.ijpharm.2022.121505</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35085732/&quot;>https://pubmed.ncbi.nlm.nih.gov/35085732</a></p></li><li><p>Wellington, K, &amp; Wagstaff, AJ (2003). Tranexamic acid: a review of its use in the management of menorrhagia. <i>Drugs</i> 63(13) 1417–1433. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200363130-00008&quot;>10.2165/00003495-200363130-00008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12825966/&quot;>https://pubmed.ncbi.nlm.nih.gov/12825966</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M01AG01;
